<?xml version='1.0' encoding='UTF-8'?>
<ns3:Response xmlns:ns4="http://www.w3.org/2001/04/xmlenc#" xmlns:ns3="urn:oasis:names:tc:SAML:2.0:protocol"
              xmlns:ns2="http://www.w3.org/2000/09/xmldsig#" xmlns="urn:oasis:names:tc:SAML:2.0:assertion"
              Destination="https://sso.inpharmative.com/IDBUS/SP-1/SAML2/ACS/POST" IssueInstant="2010-07-28T15:57:45Z"
              Version="2.0" InResponseTo="idCD35E2C53C794978" ID="FIMRSP_19c612f5-012a-112a-b1eb-97bdafc44e9d">
    <Issuer Format="urn:oasis:names:tc:SAML:2.0:nameid-format:entity">
        https://login.primetherapeutics.com/fim/sps/saml20p1/saml20
    </Issuer>
    <ns3:Status>
        <ns3:StatusCode Value="urn:oasis:names:tc:SAML:2.0:status:Success"/>
    </ns3:Status>
    <Assertion IssueInstant="2010-07-28T15:57:45Z" ID="Assertion-uuid19c612e9-012a-16a8-abd6-97bdafc44e9d"
               Version="2.0">
        <Issuer Format="urn:oasis:names:tc:SAML:2.0:nameid-format:entity">
            https://login.primetherapeutics.com/fim/sps/saml20p1/saml20
        </Issuer>
        <ns2:Signature xmlns="http://www.w3.org/2000/09/xmldsig#" Id="uuid19c612ea-012a-136f-b677-97bdafc44e9d">
            <SignedInfo>
                <CanonicalizationMethod Algorithm="http://www.w3.org/2001/10/xml-exc-c14n#"/>
                <SignatureMethod Algorithm="http://www.w3.org/2000/09/xmldsig#rsa-sha1"/>
                <Reference URI="#Assertion-uuid19c612e9-012a-16a8-abd6-97bdafc44e9d">
                    <Transforms>
                        <Transform Algorithm="http://www.w3.org/2000/09/xmldsig#enveloped-signature"/>
                        <Transform Algorithm="http://www.w3.org/2001/10/xml-exc-c14n#">
                            <xc14n:InclusiveNamespaces xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
                                                       xmlns:xs="http://www.w3.org/2001/XMLSchema"
                                                       xmlns:samlp="urn:oasis:names:tc:SAML:2.0:protocol"
                                                       xmlns:saml="urn:oasis:names:tc:SAML:2.0:assertion"
                                                       xmlns:ds="http://www.w3.org/2000/09/xmldsig#"
                                                       xmlns:xc14n="http://www.w3.org/2001/10/xml-exc-c14n#"
                                                       PrefixList="xsi xs saml"/>
                        </Transform>
                    </Transforms>
                    <DigestMethod Algorithm="http://www.w3.org/2000/09/xmldsig#sha1"/>
                    <DigestValue>p6JmPpDhMoc6KuzXvrx44l0GnfY=</DigestValue>
                </Reference>
            </SignedInfo>
            <SignatureValue>
                fVvVTHNknUBmJu/bDHeY6pLk+v9DUJSsZku1HeLIrTDk4ygn+4EatNIv4AoZUsRZFiARQA2Yu9R+aAshiJVxXFmdqv6TI83kTtkh6o3WXDSTiA5QEvQkMztJzmRxsryjV+C1r8mjzhodbyjQI2RI2zDsteSl0QCuQB9WTfyG6nM=
            </SignatureValue>
            <KeyInfo>
                <X509Data>
                    <X509Certificate>
                        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
                    </X509Certificate>
                </X509Data>
            </KeyInfo>
        </ns2:Signature>
        <Subject>
            <NameID SPNameQualifier="https://sso.inpharmative.com/IDBUS/SP-1/SAML2/MD"
                    NameQualifier="https://login.primetherapeutics.com/fim/sps/saml20p1/saml20"
                    Format="urn:oasis:names:tc:SAML:2.0:nameid-format:transient">
                uuid19c612d4-012a-1db4-b5b0-97bdafc44e9d
            </NameID>
            <SubjectConfirmation Method="urn:oasis:names:tc:SAML:2.0:cm:bearer">
                <SubjectConfirmationData InResponseTo="idCD35E2C53C794978"
                                         Recipient="https://sso.inpharmative.com/IDBUS/SP-1/SAML2/ACS/POST"
                                         NotOnOrAfter="2010-07-28T15:58:45Z"/>
            </SubjectConfirmation>
        </Subject>
        <Conditions NotOnOrAfter="2010-07-28T15:58:45Z" NotBefore="2010-07-28T15:56:45Z">
            <AudienceRestriction>
                <Audience>https://sso.inpharmative.com/IDBUS/SP-1/SAML2/MD</Audience>
            </AudienceRestriction>
        </Conditions>
        <AuthnStatement SessionNotOnOrAfter="2010-07-28T16:57:45Z"
                        SessionIndex="uuid19a80e2b-012a-158d-a05d-97bdafc44e9d" AuthnInstant="2010-07-28T15:57:45Z">
            <AuthnContext>
                <AuthnContextClassRef>urn:oasis:names:tc:SAML:2.0:ac:classes:Password</AuthnContextClassRef>
            </AuthnContext>
        </AuthnStatement>
        <AttributeStatement>
            <Attribute NameFormat="urn:oasis:names:tc:SAML:1.0:assertion" Name="ptipersonid">
                <AttributeValue xmlns:xs="http://www.w3.org/2001/XMLSchema"
                                xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="xs:string">A12343
                </AttributeValue>
            </Attribute>
        </AttributeStatement>
    </Assertion>
</ns3:Response>

